Egyesült Államok - angol - NLM (National Library of Medicine)

st. mary's medical park pharmacy - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration ( 2.1)] . tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions ( 7.1, 7.2)]. pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m 2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m 2 basis, did not show evidence of teratogenicit

Egyesült Államok - angol - NLM (National Library of Medicine)

bryant ranch prepack - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th

Egyesült Államok - angol - NLM (National Library of Medicine)

remedyrepack inc. - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [ see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m 2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m 2 basis, did not show evidence of teratogenicity. ti

Egyesült Államok - angol - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th

Egyesült Államok - angol - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration ( 2.1)] . tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions ( 7.1, 7.2)]. pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m 2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m 2 basis, did not show evidence of teratogenicit

Egyesült Államok - angol - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th

Egyesült Államok - angol - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th

Egyesült Államok - angol - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [ see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m 2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m 2 basis, did not show evidence of teratogenicity. ti

Egyesült Államok - angol - NLM (National Library of Medicine)

major pharmaceuticals - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th

Egyesült Államok - angol - NLM (National Library of Medicine)

proficient rx lp - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine tablets, usp is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine tablets, usp should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration(2.1) ]. tizanidine tablets, usp is contraindicated in patientstaking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1 , 7.2 ) ]. pregnancy category c tizanidine tablets, usp has not been studied in pregnant women. tizanidine tablets, usp should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times th